An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma
Clinical trial NCT00597116 · TERMINATED
Trial details
- NCT number
- NCT00597116
- Sponsor
- Genzyme, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2010-01-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.